Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lycium barbarum fruit extract, commonly known as goji berry or wolfberry extract, is a botanical extract derived from the fruit of the *Lycium barbarum* plant. It is widely used in traditional Chinese medicine and as a dietary supplement due to its high concentration of bioactive compounds, including *Lycium barbarum* polysaccharides (LBP), carotenoids (zeaxanthin), flavonoids, and betaine. Research indicates potential therapeutic benefits in neurodegenerative diseases like Parkinson's disease, where it may protect neurons by maintaining mitochondrial homeostasis and dopamine levels. It also demonstrates anticancer properties, particularly in estrogen receptor-positive breast cancer, by modulating estrogen metabolism. Additionally, it is valued for its antioxidant, anti-aging, and immunomodulatory effects.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on lycium barbarum fruit extract.